Transcriptomics

Dataset Information

0

Stem cell secretome-treatment improves whole-body metabolism, reduces adiposity and promotes skeletal muscle function in aged mice


ABSTRACT: Aging coincides with the progressive loss of muscle mass and strength, increased adiposity, and diminished physical function. Accordingly, interventions aimed at improving muscle, metabolic, and/or physical health are of interest to mitigate the adverse effects of aging. In this study, we tested a stem-cell secretome product which contains a host of growth, cytoskeletal remodeling, and immunomodulatory factors. We examined the effects of 4 weeks of bi-weekly unilateral intramuscular secretome injections (quadriceps) in ambulatory aged male C57Bl/6 mice (22-23 months) compared to saline injected aged-matched controls. After 4 weeks of treatment, secretome delivery substantially increased whole body lean mass and decreased fat mass corresponding to higher fiber cross sectional area and smaller adipocyte size, respectively. Secretome-treated mice also displayed improved whole-body grip strength and rotarod performance and had higher energy expenditure and physical activity levels compared to control mice. Furthermore, secretome-treated mice had greater skeletal muscle Pax7+ cell abundance, capillary density, and collagen turnover. Finally, the secretome product reduced lipid content and lipid droplet size in adipocytes in vitro. These data suggest intramuscular treatment secretome improves whole-body metabolism, physical function, and remodels skeletal muscle and adipose tissue in aged mice.

ORGANISM(S): Mus musculus

PROVIDER: GSE242211 | GEO | 2024/07/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-07-22 | E-GEOD-74570 | biostudies-arrayexpress
2016-07-22 | GSE74570 | GEO
2022-11-06 | GSE217037 | GEO
2023-02-04 | GSE144304 | GEO
2008-06-16 | E-GEOD-9484 | biostudies-arrayexpress
2021-08-23 | PXD020575 | Pride
2023-04-27 | PXD036532 | Pride
2007-11-02 | GSE9484 | GEO
2021-09-01 | GSE167462 | GEO
| 47924 | ecrin-mdr-crc